Serves as a subject matter expert for cell and gene therapy and cell-based therapeutic platforms; familiarity with AAV or other viral vectors, baculovirus-based expression systems, insect cell platforms, oligonucleotides, nucleic acid-based therapeutics, or other emerging modalities is a plus. Provides expert technical input and scientific oversight for work conducted with external development and manufacturing partners, including CDMOs, CROs, technology providers, and strategic collaborators; supports technical scope definition, deliverable review, issue investigation, and risk mitigation.